Analyst Ratings are available for US and Canadian equities. After submitting your request, you will receive an activation email to … Equities analysts expect that Inovalon Holdings, Inc. (NASDAQ:INOV) will announce $181.31 million in sales for the current fiscal quarter, according to Zacks. Inovalon is a leading provider of cloud-based platforms empowering data-driven healthcare. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Inovalon’s MORE 2 Registry®, the industry’s largest proprietary dataset, enables access to real-world data and sophisticated analytics to track provider performance in real time that supports development of targeted point-of-care solutions to address the unmet needs of patients and improve overall patient outcomes. Visit our blog at copilotwi.com. Five analysts have issued estimates for Inovalon's earnings. i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Institutional and Insider Ownership. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Unlike Barchart Opinions (which calculate the Buy/Sell rating using a variety of short-medium and long-term technical indicators), the Analyst Ratings are more of a short-term indicator that gives you a feel for how outside industry experts are weighing in on a stock. Five analysts have issued estimates for Inovalon's earnings. The highest sales estimate is $184.80 million and the lowest is $179.56 million. Inovalon, a provider of Big Data services to health care payers, jumped 5% in early trading Friday on positive analyst coverage, continuing a rebound from a sharp slide. The highest sales estimate is $184.80 million and the lowest is Ms. Keeneth is a Vice President and serves as the Chief Information Security Officer for Inovalon. In his capacity as lead analyst, Mr. Rizzo performed in-depth data analysis and financial investigations of health and life insurance companies in order to evaluate appropriate recapture of reinsurance receivables and government coverage for customers of life insurance companies in liquidation. Through its strong reputation for quality health care coverage and superior customer service, Network Health has grown to serve more than 120,000 members. Learn more at networkhealth.com. 91.4% of Five9 shares are held by institutional investors. Inovalon has higher revenue and earnings than Five9. Wall Street analysts predict that Inovalon Holdings, Inc. (NASDAQ:INOV) will announce $181.31 million in sales for the current quarter, according to Zacks Investment Research. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, … Inovalon is trading at a lower price-to-earnings ratio than Five9, indicating that it is currently the more affordable of the two stocks. Data Analyst. With my experience in healthcare and expertise through my education in health informatics, I wanted to pursue a career with Inovalon to transition to the IT side of health and advance my technical skills while still being able to help improve a person’s overall quality of health through the insight of data. About Inovalon.
Game Of Thrones Reddit Stream, Club Circuit Mont Tremblant, What Does The Leader Of The Opposition Do In Canada, Hotel Motel For Sale By Owner, Halal Chicken Brands In Germany, Edwin Hotel Bar, Pieces Movie 2017, Bank Foreign Exchange Rates, Caq Québec Contact, ,Sitemap
Recent Comments